APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19
April 02, 2020 02:12 ET
|
APEIRON Biologics
Regulatory approvals obtained for the treatment of 200 COVID-19 patients in Austria, Germany and Denmark; Austrian government to provide significant financial supportAPN01 has the potential to block...